Genmab — Juni 2018

[Helge_LarsenPI-redaktør]

A/B forsætter med salget i dag.

[Parasitism]

Det skal jeg da love for. Utroligt der ikke er nok interesse på købersiden til at holde kursen oppe, i dette niveau.

[Plimsoller]

Det er stadigvæk tossetimen, så det kan nå at ændre sig

[Parasitism]

Korrekt

[Helge_LarsenPI-redaktør]

Genmab: Darzalex er blevet fjernet fra studie med PD-1-hæmmer: http://www.proinvestor.com/investornyt/538510/genmab-darzalex-er-blevet-fjernet-fra-studie-med-pd-1-haemmer

[Parasitism]

[Bella1]

Måske et klogt træk, - man skal vel ikke blande ægte guld med guldbronce, det gir rammen et trist skær

[Sukkeralf]

Jamen så er der da yderligere en forklaring på at vi falder og falder

[E_L]

well, at least Medwatch got them to make that statement.... (i asked Genmab and JNJ 3 weeks ago, but they did not reply)

[Sukkeralf]

Unfortunately Genmab to me is getting more and more into covering up problems -thats kind of dangerous !!

[Sukkeralf]

Its very easy to be transparent when things goes well - the real deal is when things are not progression without problems

[E_L]

yes, i get your point...

[E_L]

in their defence, they have grown very fast from a very small company to what they are now

[E_L]

and they do not control all the Dara info...

[E_L]

i find JNJ is playing a very dubious role in all of this…

[Sukkeralf]

I kind of think more that its not as important for Janssen and they maybe are a bit itired of Genmab/jan talking too much

[Sukkeralf]

My problem with Genmab right now is - that a long time ago when Genmab started these new adventures they promissed to be transparent. And they have managed that quite perfect all the way up but know when we start to see problems again they turn back to hiding thing and not telling much.

[E_L]

unfortunately they probably can not tell much more as they have to wait for JNJ for that info. JNJ controls.

[Mcjean]

What do you expect them to tell? They dont have acces to Dara and they most be silent if they dont want to go to court.

[E_L]

and JNJ have said all along they consider Genmab as good partners, clearly their strategy and communication so far could have been much better to help that good partner...